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Cancer is the second cause of overall 
 mortality in the world (Abegunde et al., 
2007), with approximately 12.5 million 
new cases and 7.5 million deaths each 
year (Ferlay et al., 2010; Jemal et al., 2011). 
Many cancers are preventable, and cancer 
control represents a global challenge which 
will be significantly aided by increasing 
our knowledge of distribution, causes, and 
methods for prevention of cancer. This 
journal, Frontiers in Cancer Epidemiology 
and Prevention, is dedicated to publish-
ing papers on the distribution, etiology, 
and prevention of cancer. In this article, 
we present our vision for the Journal. We 
discuss what has been discovered, what lies 
ahead, and what papers we hope to receive 
from authors. The overall scope of the 
Journal is summarized in Figure 1.
In the past few decades, cancer registries 
have produced data on incidence, preva-
lence, and mortality of cancers in many 
regions of the world, and shown variations 
by sex, race, geographic region, and other 
demographic determinants. Examples 
include the Surveillance Epidemiology 
and End Results (SEER) program in the 
United States (Hayat et al., 2007) and the 
compilation of cancer registry data within 
the volumes of Cancer Incidence in Five 
Continents (Parkin et al., 2010). We now 
have a reasonably good idea of distribu-
tion of cancers in many areas of the world, 
overall and within specific subgroups of the 
population. This is a unique and fortunate 
characteristic of the descriptive epidemiol-
ogy of cancer, compared to other chronic 
diseases. However, cancer incidence and 
mortality rates change; hospitals and cancer 
registries prepare new reports; and new reg-
istries are established. We welcome reports 
on the incidence, prevalence, and mortality 
from cancers from all over the world and 
manuscripts based on original analyses of 
descriptive data.
Whereas by 1950 little was established 
about etiology of cancer, epidemiologic 
studies in the past 60 years have helped us 
know about some major causes of many 
cancers. One can cite many examples. 
Groundbreaking case–control studies by 
Doll and Hill (1950), Wynder and Graham 
(1950), and Levin et al. (1950) in the early 
1950s established smoking as a cause of can-
cer. In the past two decades, a large number 
of case–control, cohort, and nested case–
control studies showed the strong asso-
ciation between certain types of human 
papillomavirus (HPV) and cervical cancer, 
and later cancers of the vulva, vagina, penis, 
anus, oral cavity, and oropharynx and tonsil 
(Munoz et al., 2003; Bouvard et al., 2009). 
The causal role of hepatitis B virus (HBV) 
and hepatitis C virus (HCV) infection in 
hepatocellular carcinoma (Bouvard et al., 
2009) and of several occupational exposures 
in a variety of cancers (Baan et al., 2009) are 
other important examples. Likewise, since 
2006, genome-wide association studies 
have shown over 100 associations between 
common genetic polymorphisms and risk 
of various cancers (Stadler et al., 2010). 
Notwithstanding these discoveries, there 
remains much to be understood in rela-
tion to the etiology of cancer. Association 
of physical activity (Prentice et al., 2004; 
Reeves et al., 2007), shift-working (Straif 
et al., 2007; Stevens et al., 2011), and expo-
sure to many chemical agents and mixtures 
(Ritz and Rull, 2008; Olsson et al., 2011) 
with cancer are a few examples. Studying 
environmental risk factors of cancer, from 
childhood, in repeated measures, with 
considering potential modifying effect of 
other factors such as microbiome, and in 
the light of development and teratogenesis, 
may increase our understanding of cancer 
risk factors (Wild, 2005, 2011; Hanash, 
2011; Perera, 2011; Potter, 2011; Rappaport, 
2011; Spitz, 2011). The continuing decline 
in cost of sequencing will make it possible to 
identify rare polymorphisms that strongly 
increase risk of cancer. The Journal wel-
comes reports on new factors associated 
with risk of cancer that may have a possible 
etiologic role, as well as null results from 
high-quality studies.
Epidemiologic studies can use new 
instruments or refine modeling to provide 
better understanding of the causes of can-
cer. For example, it has been suggested that, 
compared to food frequency questionnaires, 
using multiple 24-h recalls may increase our 
ability to measure diet more accurately and 
hence reduce measurement error (Schatzkin 
et al., 2009b). During the past few decades, 
a wide range of biomarkers has also been 
applied to cancer epidemiology (Boffetta, 
2010; Hartman et al., 2010). A classic exam-
ple of successful application of biomarkers 
in cancer epidemiology is the study between 
aflatoxins and risk of hepatocellular carci-
noma (Ross et al., 1992). However, intra-
individual variability (e.g., diurnal variation 
in hormonal level) and measurement error 
(e.g., sampling and laboratory variation) 
do also occur with biomarkers, and most 
biomarker studies rely on a single biologi-
cal sample, which may not represent long-
term exposures. Many investigations are 
being conducted to identify new biomar-
kers and improve the validity and preci-
sion of existing biomarkers. Cancer results 
from a complex interplay of environmental, 
genetic, and epigenetic factors (Spitz and 
Bondy, 2010). New modeling strategies have 
increased our ability to more accurately 
study well-established associations such 
as the association between smoking and 
lung cancer (Lubin et al., 2008), as well as 
the association of diet (Ferrari et al., 2008; 
Schatzkin et al., 2009a) or genetic factors 
(Pashayan et al., 2011; Wakefield et al., 2010) 
with cancer, and to better control the effects 
of confounding factors (de Vocht et al., 
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(Callinan et al., 2010) and are expected 
to reduce the burden of tobacco-related 
cancers in those populations (Alberg 
et al., 2007; Sturgis and Cinciripini, 2007). 
Discovery of HPV as a cause of cervical 
cancer has successfully led to the develop-
ment of effective vaccines against potent 
carcinogenic types of HPV (Monsonego 
et al., 2010). Global vaccination of new-
borns against HBV is another example of 
success that has reduced the rate of hepa-
tocellular carcinoma in Taiwan (Chang 
et al., 2009) and would likely lead to seri-
ous declines in the worldwide rates in 
the coming decades (Yang and Roberts, 
2010). Rapid reduction of the cost of 
genetic information has made it possible 
to screen and take actions when cancer risk 
(Brennan et al., 2004; Allen et al., 2009; 
Hashibe et al., 2009; Cook et al., 2010; 
Gallicchio et al., 2010; Zheng et al., 2011). 
Requirements and considerations for suc-
cessful execution of large studies and mak-
ing fruitful collaborations between multiple 
groups have been discussed elsewhere 
(Boffetta et al., 2011). We invite papers from 
such consortia and large-scale studies.
Cancer prevention, using the knowl-
edge from epidemiology and molecular 
biology, has achieved many successes. 
Recognition of smoking as an impor-
tant cause of lung cancer has resulted in 
smoking control policies in Europe, the 
United States, and some other countries 
(Chaloupka et al., 2011) that have in 
turn reduced exposure to tobacco smoke 
2009). The Journal accepts papers on new 
instruments or biomarkers, improved sta-
tistical models, and also stronger studies of 
previously known associations.
Study subjects in epidemiological stud-
ies generally have heterogeneous environ-
mental exposures and genetic background, 
which interact with each other and may 
influence the association between risk fac-
tors and health outcomes. In order to study 
such interactions, epidemiologic studies 
require large sample sizes, and therefore 
epidemiology falls into the category of 
“big science” (Kreeger, 2003). Large cohort 
studies, pooling and consortia of several 
studies, networks, and “networks of net-
works” have been helpful in achieving 
large sample sizes and to study  interactions 
Figure 1 | Cancer research areas that are within the scope of Frontiers in Cancer Epidemiology and Prevention*.
*Null results from high-quality studies are also welcome.
aIncluding environmental, genetic, and epigenetic factors and their interactions.
bIncluding advances in data collection methods and biomarkers, as well as translational studies.
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predict survival much more accurately. 
Some prognostic factors are modifiable 
and active secondary prevention activities 
can be undertaken to prolong survival. For 
example, improving awareness of effective 
screening methods and enhancing health 
services to offer such screening could lead 
to downstaging of cancers. We welcome 
reports on survival of cancer patients and 
its prognostic factors, and also research on 
methods leading clinical downstaging of 
cancers.
In addition to original research papers, 
we encourage authors to submit review 
articles, systematic reviews, and meta-
analyses. These articles help establish or 
exclude associations (Kellen et al., 2007; 
Islami and Kamangar, 2008; Renehan et al., 
2008; Lee et al., 2009; Turati et al., 2010; 
Gandini et al., 2011), revise estimates of ini-
tially inflated associations that may happen 
due to publication bias (Kamangar et al., 
2006a), suggest associations or interactions 
relevant to cancer research (Minelli et al., 
2011), or identify gaps in a research field 
(Islami et al., 2009).
Whereas the Journal is mainly dedicated 
to human studies, we also invite papers on 
animal or laboratory studies that have a 
direct relevance to cancer prevention in 
humans (Kern et al., 1991; Kim et al., 1991; 
Jokelainen et al., 1994; Watanabe et al., 1998; 
Wang et al., 2010). For example, papers that 
show high amounts of mutagenic or car-
cinogenic substances in certain foods and 
beverages (Zhang et al., 1983; Kamangar 
et al., 2008; Perello et al., 2008) will fall in 
the repertoire of this Journal.
In summary, while we have learned 
much about the distribution, etiology, pri-
mary and secondary prevention of cancer 
in one century of systematic research, many 
things remain to be learned. Development 
of large-scale trials and cohort studies, 
consortia of analytical epidemiology stud-
ies, new statistical methods, novel meas-
urement methods, ever-increasing ability 
to sequence genome, among other factors, 
are giving us the opportunity to delve more 
deeply into research questions. We believe 
that Frontiers in Cancer Epidemiology and 
Prevention will play an important role in 
disseminating new knowledge in this field 
and can increase communication among 
basic scientists, epidemiologists, clinicians, 
and public health professionals in the field 
of oncology.
is very high, such as in individuals with 
certain BRCA1 mutations (Balmana et al., 
2010). On the other hand, cancer preven-
tion science has also faced many failures. A 
number of initially promising agents were 
later shown to have either no effect or even 
cause harm. Well-known examples include 
the failure of alpha-tocopherol and beta-
carotene in preventing lung cancer (The 
Alpha-Tocopherol, Beta Carotene Cancer 
Prevention Study Group, 1994) and failure 
of selenium in preventing prostate cancer 
(Lippman et al., 2009). The Journal invites 
papers on new findings and methods on 
cancer prevention research. We are inter-
ested in receiving papers on both successes 
and failures of agents that are hypoth-
esized to prevent cancer, including che-
mopreventive agents, vaccines, or lifestyle 
modification. We especially encourage 
submission of randomized clinical trials.
The Journal also accepts papers on 
screening and secondary prevention of 
cancer. It has now been well established 
that early screening for cervical, colorec-
tal, and breast cancers through various 
methods can save lives (Sankaranarayanan 
et al., 2009; Schiffman and Solomon, 2009; 
US Preventive Services Task Force, 2009; 
Cunningham et al., 2010). New screening 
methods are being continuously devised; 
criteria are revised by age and sex; and revi-
sions are made due to changes in effective-
ness of treatments and invasiveness and 
cost of procedures. Screening studies are 
subject to a number of potential biases 
(Croswell et al., 2010), and new studies 
often refine previous studies and correct 
for biases. Publications of high-quality 
screening studies are within the scope of 
this Journal.
With rising availability of early detection 
facilities and more efficient treatments, sur-
vival of cancer patients has increased over-
all (Jemal et al., 2010). Survival has been 
shown to be related to a number of factors, 
including cancer site (e.g., breast versus 
pancreatic cancer), stage, age, other demo-
graphic, lifestyle, and genetic factors, as well 
as availability of facilities for early diagnosis 
or treatment of cancers. Consequently, can-
cer survival can vary across individuals and 
populations (Kamangar et al., 2006b; Jemal 
et al., 2010; Slatore et al., 2010; Coleman 
et al., 2011). However, many prognostic 
factors are not yet known. For example, 
low-cost sequencing may enable us to 
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